News Release

Development Recognition of HD-4 Multi-Domain Cardiac Heart Monitor

Date: 1999/10/26

The President of International Wex Technologies Inc. ("IWT"), Mr. Frank Shum SC.M., along with Dr. John Fisher SC.D., M.E.E., and Sidney Baumgarten J.D., have had a lengthy article published in the September 1999 issue of Medical Electronics and Equipment Manufacturing (http://www.mac-med.com), of Pittsburgh, P.A., U.S.A. In this article, the writers explain the future of non-invasive heart monitoring. IWT holds the fundamental patent that is required to be used in this type of cardiac monitoring. The full text will be available in our website http://www.wextech.ca, or as alternative, we can fax or mail it to you if requested.

IWT has developed a patented new product named Tetrodin(HT). Tetrodin(HT) is a non-narcotic pharmaceutical that has proven to be a safe and effective treatment for all opiate (heroin, opium, morphine, methadone, etc.) addictions. Tetrodin(HT) functions very well in both primary withdrawal treatment and abstinence maintenance (longer term use) of drug addiction.

For additional information on Tetrodin(HT), view the IWT website at http://www.wextech.ca or call Howard Milne , V. P. Shareholder Communications, at 604-683-8880 or 1-800-722-7549.

Per: Donna Shum, Corporate Secretary